Lower toxicity than conventional chemo
Please join our staff as we participate or present in the following presentations at the 2018 ASH Annual Meeting
Groundbreaking study paves way for targeted therapy
Search our Cancer Clinical Trials Database for a full listing of all open and accruing studies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Gene signatures differentiate clinical response
10-year outcomes favor autologous over implant
Initial study results are encouraging
Higher doses don’t mean higher toxicity
New system better predicts patient outcomes
May help identify patients for immunotherapy
Advertisement
Advertisement